Ischemic Stroke clinical trials at UC Irvine
3 in progress, 2 open to eligible people
Milvexian in Participants After an Acute Ischemic Stroke or High-Risk Transient Ischemic Attack- LIBREXIA-STROKE
open to eligible people ages 40 years and up
The purpose of this study is to evaluate whether milvexian compared to placebo reduce the risk of recurrent ischemic stroke.
Irvine 5359777, California 5332921 and other locations
Sleep for Stroke Management and Recovery Trial
open to eligible people ages 18 years and up
The purpose of this study is to determine whether treatment of obstructive sleep apnea (OSA) with positive airway pressure starting shortly after acute ischemic stroke (1) reduces recurrent stroke, acute coronary syndrome, and all-cause mortality 6 months after the event, and (2) improves stroke outcomes at 3 months in patients who experienced an ischemic stroke.
Orange 5379513, California 5332921 and other locations
Determinants of the Effectiveness of Robot-assisted Hand Movement Training
Sorry, in progress, not accepting new patients
The investigators would like to investigate the effectiveness of somatosensory training for robot-assisted hand motor rehabilitation after stroke.
Irvine 5359777, California 5332921
Our lead scientists for Ischemic Stroke research studies include David Reinkensmeyer, Ph.D Masaki Nagamine, MD.
Last updated: